Lilly(Eli) & Company

NYSE: LLY
$895.87
+$10.67 (+1.2%)
Real Time Data Delayed 15 Min.

LLY Stock Chart and Intraday Price

LLY Stock Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 743,142.26M USD
Shares Outstanding 950,164,000
Eli Lilly and Company is a global leader in pharmaceuticals, focusing on discovering, developing, and marketing a wide range of human medications. With a rich history dating back to 1876 and headquartered in Indianapolis, Indiana, it offers treatments for diabetes, including a comprehensive lineup of insulin products, and type 2 diabetes medications like Jardiance and Trulicity. The company also has a strong presence in oncology, rheumatoid arthritis, dermatology, mental health, and more, with notable products such as Alimta for cancer and Cymbalta for depression. Eli Lilly collaborates with various industry partners to enhance its product offerings.

LLY Articles

Live Updates Live Coverage Has Ended S&P 500 Extends Its Winning Streak 4:18 pm The S&P 500 closed up 0.6% for Tuesday, extending its winning streak to six straight days. Trade Talks Keep...
Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 trillion stock and the first healthcare company to do so. Trading at $852 per...
Live Updates Live Coverage Has Ended All's Well That Ends Green 4:30 pm All three major market indices ended in the green Friday. The Dow Jones Industrial Average closed up a bare 0.05%, while the...
Live Updates Live Coverage Has Ended A Bad Day for Investors Got Much, Much Worse 4:08 pm A trading day that started out bad for investors this morning ended in a market rout. By the time the closing...
24/7 Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.
The Dow Jones Industrial Average is tumbling by another 440 points in midday trading today, as President Trump criticized Federal Reserve chairman Jerome Powell’s position, but the fact he is not...
One man’s trash may be another man’s treasure, but dumpster diving when investing carries risks. You have to wade through a lot of junk to potentially find a nugget of gold. While cheap stocks...
The stock market has been on edge since the announcement of tariffs, reporting its biggest loss since March 2020. The damage continues and about 80% of the S&P 500 companies were in red this...
Dividend stocks have been a reliable cornerstone for those who want to anchor their portfolios when markets get shaky. These stocks give you a steady stream of income and often appreciate during...
Stock splits tend to create a lot of buzz in the market, especially when some of the most prominent companies announce a split. Whenever the stock prices hit a higher range, the management decides to...
The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk‘s (NYSE:NVO) was over. It said the Danish pharmaceutical had sufficient supply of its...
The big pharma sector is one that’s generally fallen out of favor for many investors over the past few decades, as large healthcare companies have seen slower growth and consolidation hasn’t...
Shares of Hims & Hers Health (NYSE:HIMS) are down about 21%, or $14. All on news the Ozempic shortage is over. About This Article  Just this morning, the US FDA said Novo Nordisk’s popular...
President Trump is going scorched earth on America’s major European trading partners. Vowing to impose reciprocal tariffs on “every country” that hits U.S. products coming into their countries...
AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50 years.